Follow us on :


Hematology and Medical Oncology

Online ISSN: 2398-8495

Journal Impact Factor: 1.96

NLM ID: 101695840

Ciro Rinaldi (Editor-in-Chief)

University of Lincoln, Italy

Hematology and Medical Oncology is an open access journal with comprehensive peer review policy and a rapid publication process.  HMO is a novel journal that will focus on clinical as well as basic science research reports in hematology and oncology including all major types of malignancies, blood disorders, and experimental therapies. The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors and also accept papers on clinical research with clinical trials, including investigator-initiated, NCI-sponsored and pharmaceutical industry sponsored phase I-III trials. Translational studies applying basic science to clinical issues are particularly welcomed.

Hematology and Medical Oncology will feature original research, review papers, clinical studies, editorials, expert opinion and perspective papers, commentaries, case reports, brief reports and book reviews.

Hematology and Medical Oncology welcomes direct submissions from authors: Attach your word file with e- mail and send it to submissions@oatext.com alternatively to editor.hmo@oatext.com

Please, follow the Instructions for Authors. In the cover letter add the name and e-mail address of 5 proposed reviewers (we can choose them or not).

Copyright is retained by the authors and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by Hematology and Medical Oncology, is properly cited

Ciro Rinaldi


Professor Ciro Rinaldi trained in Italy at University Federico II Naples, where he gained his MD, followed by Haematology specialist training and a PhD in Biotechnology.  During his PhD, he moved to Chicago where he worked in Giuseppina Nucifora’s Lab at University of Illinois (UIC), and he published several articles on alternative pathways in MPN and MDS.

He is Consultant Haematologist at United Lincolnshire Hospital Trust specialised in MPN, MDS, Myeloma and Lymphoma and he is also Clinical Director for Clinical Support Services and Deputy Director Clinical Research Facilities.

He became Visting Professor in Biomedical Science at University of Lincoln in 2015 where He leads the MPN/MDS molecular biology lab focusing on Philadelphia-negative MPN and abnormal pathways in MDS.

In 2014 he became the Haematology Expert Clinical Advisory Group (ECAG) Lead for the East Midland.

Editorial Board


Jan Jacques Michiels

Professor
Senior Internist
International Hematology and Bloodcoagulation Research Center,
Goodheart Institute and Foundation in Nature Medicine,
European Working Group on Myeloproliferative Neoplasms,
The Netherlands

William Ebomoyi

Department of Health Studies,
College of Health Sciences,
Chicago State University
USA

Jalid Sehouli

Professor, Director
Department of Obstetrics with Centre for Oncological Surgery
Head of the European Competence Center for Ovarian Cancer Campus
Universitätsmedizin Berlin Charité
Medical University of Berlin Augustenburger
Germany


Samar Masoumi-Moghaddam

Center for Immunotherapy Roswell Park Cancer Institute
Elm & Carlton Streets
USA

Diana O. Treaba

Associate Professor of Pathology Hematopathologist, Anatomic and Clinical Pathologist Director, Hematopathology Laboratories at Rhode Island Hospital and Miriam Hospital, USA

Afshin Amini

St George Hospital
The University of New South Wales
Sydney
Australia


Felicetto Ferrara

Division of Hematology and Stem Cell Transplantation Unit Cardarelli Hospital, Naples, Italy

Ayelet Shai

Oncology Department
Galilee Medical Ceneter, Nahariya
Bar Ilan Faculty of Medicie
Zefad,Israel

Augusta Silveira

Faculty of Health Sciences Fernando Pessoa University Praça 9 de Abril, Porto, Portugal


Jamal Khader

Radiation Oncologist Director, Radiation Oncology Residency Program Radiation Oncology Department, Jordan

Dr. Kadir CETINKAYA

Obstetrics and Gynecology General Surgery Ankara Oncology Education and Research Hospital Ankara, Turkey

Rongbiao Tang

Department of Radiology
Ruijin hospital, School of Medicine
Shanghai Jiao Tong University (SJTU)
China


Antonio Russo

Medical Oncology Director
Department of Oncology
A.O.U.P. "P. Giaccone" University Hospital
Designated Centres of Integrated Oncology and Palliative Care
Palermo, Italy

Dr Petar Avramovski

Specialist of internal medicine
Department of Internal medicine
Clinical Hospital-Bitola, Macedonia

Katarina Baluchova

Jessenius Faculty of Medicine in Martin
Commenius University
Slovakia


Caroline Brunetto de Farias

Laboratório de Pesquisas em Câncer
Hospital de Clínicas de Porto Alegre
Porto Alegre, Brazil

Kaiser Jamil

Professor and Honorary Director
School of Biotechnology and Bioinformatics
Mahatma Gandhi National Institute for Research and Social Action (MGNIRSA)
Hyderabad, India

Giuseppe Luigi Banna

Clinical Head
Division of Medical Oncology
Cannizzaro Hospital–Catania
Italy.


Marwa Monier Mahmoud Refaie

Faculty of medicine
Minia University
Egypt

Alfredo Addeo

Senior consultant oncologist
University Hospital of Geneva
Switzerland

Prof. Francesco Buccisano

Cattedra Di Ematologia
Univerista Tor Vergata Di Roma
Italy

In Press

Volume 4, Issue 1


Will be updated soon.

Current Issue

Volume 3, Issue 4


Gender specific aspects in patients with mantle cell lymphoma undergoing rituximab-based therapy – what role does gender play?

Wolfgang Lamm Barbara Kiesewetter Philipp Bauer Georg Jeryczynski Markus Raderer

Research Article-Hematology and Medical Oncology (HMO)

October 01, 2018


Dysregulation in Cortisol Diurnal Activity among Myeloproliferative Neoplasms Cancer Patients

Maricarmen Vizcaino Jennifer Huberty Linda Larkey J Heidi Kosiorek Krisstina Gowin Ryan Eckert Ruben A Mesa

Research Article-Hematology and Medical Oncology (HMO)

October 11, 2018


The use of meditative movement as a non-pharmacologic approach in hematological cancer patients: A systematic review of the literature

Ryan Eckert Jennifer Huberty Linda Larkey Lisa Marks Ruben Mesa

Research Article-Hematology and Medical Oncology (HMO)

October 18, 2018


Pembrolizumab for platinum refractory small cell carcinoma of the prostate, case report

Salhab M Donahue M Walsh W

Case Report-Hematology and Medical Oncology (HMO)

October 29, 2018


The mutational landscape of chronic neutrophilic leukemia: case report and literature review

Stephen E. Langabeer Ezzat Elhassadi

Case Report-Hematology and Medical Oncology (HMO)

November 01, 2018


Composite splenic marginal zone lymphoma and mantle cell lymphoma with p53 deletion and tetraploidization

David Azoulay Eugene Dementiev Luba Trakhtenbrot Netanel Horowitz Tamar TadmorLuiza Akria

Case Report-Hematology and Medical Oncology (HMO)

November 02, 2018


Archive


Volume 3

Gender specific aspects in patients with mantle cell lymphoma undergoing rituximab-based therapy – what role does gender play?

Wolfgang Lamm Barbara Kiesewetter Philipp Bauer Georg Jeryczynski Markus Raderer

Research Article-Hematology and Medical Oncology (HMO)

October 01, 2018


Dysregulation in Cortisol Diurnal Activity among Myeloproliferative Neoplasms Cancer Patients

Maricarmen Vizcaino Jennifer Huberty Linda Larkey J Heidi Kosiorek Krisstina Gowin Ryan Eckert Ruben A Mesa

Research Article-Hematology and Medical Oncology (HMO)

October 11, 2018


The use of meditative movement as a non-pharmacologic approach in hematological cancer patients: A systematic review of the literature

Ryan Eckert Jennifer Huberty Linda Larkey Lisa Marks Ruben Mesa

Research Article-Hematology and Medical Oncology (HMO)

October 18, 2018


Pembrolizumab for platinum refractory small cell carcinoma of the prostate, case report

Salhab M Donahue M Walsh W

Case Report-Hematology and Medical Oncology (HMO)

October 29, 2018


The mutational landscape of chronic neutrophilic leukemia: case report and literature review

Stephen E. Langabeer Ezzat Elhassadi

Case Report-Hematology and Medical Oncology (HMO)

November 01, 2018


Composite splenic marginal zone lymphoma and mantle cell lymphoma with p53 deletion and tetraploidization

David Azoulay Eugene Dementiev Luba Trakhtenbrot Netanel Horowitz Tamar TadmorLuiza Akria

Case Report-Hematology and Medical Oncology (HMO)

November 02, 2018


What is the role of surgery in stage III NSCLC in the era of immunotherapy?

Addeo A Bianchi D Minervini F

Mini Review-Hematology and Medical Oncology (HMO)

June 25, 2018


Overall Survival is not the only Endpoint to Measure Clinical Relevance

Picardi C Di Maio M Addeo A

Commentary-Hematology and Medical Oncology (HMO)

June 29, 2018


Integrating New Treatment Options into the Management of Adult ITP

James Granfortuna

Review Article-Hematology and Medical Oncology (HMO)

August 13, 2018


Fine needle aspiration cytology guided by ultrasound of suspicious axillary lymph nodes in breast cancer patients

Waldeir de Almeida Junior Alexandre de Almeida Barra Henrique Moraes Salvador Silva Marco Antonio Dias Filho Henrique Lima Couto Breno Bernardes de Souza Belo Horizonte

Research Article-Hematology and Medical Oncology (HMO)

September 17, 2018


Kaposi Sarcoma among non-HIV patients with hematological malignancy: An unusual reality

Giamal Edin Gmati Farhan Khalid Abdullah Abdulaziz Alharbi Muhammad Al-Nahdi Ahmed Alaskar

Case Report-Hematology and Medical Oncology (HMO)

September 24, 2018


Severe aplastic anemia during osimertinib treatment in a non-small cell lung cancer patient harboring EGFR T790M mutation

Seo Ree Kim Jihyun Han Jae-Ho Yoon Jeong-Oh Kim Jin hyoung Kang

Case Report-Hematology and Medical Oncology (HMO)

September 27, 2018


Unusual case of IgE multiple myeloma: case report

Malary Mani Wen Fan Katherine Hawkins

Case Report-Hematology and Medical Oncology (HMO)

March 23, 2018


Papillary thyroid microcarcinoma: active surveillance in the follow-up of persistence structural disease

P Bellitti A Carbone D Cito R Bruno

Letter to the Editor-Hematology and Medical Oncology (HMO)

March 26, 2018


Creation of anticancer drugs employing metal-containing macromolecules

Charles EC Jr Michael RR

Review Article-Hematology and Medical Oncology (HMO)

April 20, 2018


Is there any advantage from continuation of trastuzumab beyond progression in metastatic her positive gastric cancer? report of two cases and literature review

Rachid Tanz Tarik Mahfoud Ilyas El Alami Aziz Bazine Hassan Errihani Mohamed Ichou

Case Report-Hematology and Medical Oncology (HMO)

April 20, 2018


Synthesis of organotin polymers from 2-ketoglutaric acid and their ability to inhibit the growth of human cancer cell lines

Charles E. Carraher Jr Michael R. Roner Dhruvin Patel Lindsey C. Miller Alisa Moric-Johnson Paul Slawek Francesca Mosca Jessica Frank

Research Article-Hematology and Medical Oncology (HMO)

February 28, 2018


Dietary iodine intake, thyroid diseases and the prevalence of papillary carcinoma (PTC)

George Zhu

Review Article-Hematology and Medical Oncology (HMO)

February 17, 2018


Differential DNA damaging effects of genotoxic agents from chewing tobacco and gutka

Azad Kumar Nilesh Kumar Sharma

Research Article-Hematology and Medical Oncology (HMO)

March 09, 2018


Image guided robotic interstitial brachytherapy, a new innovative treatment for malignancies

Bhaskar Vishwanathan Sanjeet Kumar Mandal Rishabh Kumar HV Ramprakash

Research Article-Hematology and Medical Oncology (HMO)

February 27, 2018


Volume 2

Robot-Assisted Retroauricular Neck Surgery in Head and Neck Cancers

Muhammet Recai Mazlumoglu

Research Article

December 04, 2017


Gemcitabine-vinorelbine-prednisolone combination in cases with lymphoma: retrospective analysis

Semra Paydas Emine Kilic Bagir Melek Ergin

Research Article

December 18, 2017


Breast cancer associated with paraneoplastic dermatomyositis (DM); case report

Abeer Hussien Anter Samir Taha Alfotih

Case Report

December 26, 2017


Perivascular niches as points of the utmost expression of tumor microenvironment

Annovazzi Laura Mellai Marta Bisogno Ilaria Spatola Alessandra Bovio Enrica Cassoni Paola Casalone Cristina Schiffer Davide

Research Article

December 29, 2017


Archaeal genome and cancerogenesis

Stupar Milanko Stefanovic Slavica

Review Article

December 29, 2017


Diabetes Mellitus Is Associated with Hepatocellular Carcinoma: A Retrospective Study in Southwest China

Yi-Shu Tang Lang Wu Fang Cui

Research Article-Hematology & Medical Oncology (HMO)

JuLY 14, 2017


The association between oral anaerobic bacteria and acute myeloid leukemia

Mesut Öğrendi

Research Article-Hematology & Medical Oncology (HMO)

July 27, 2017


The design and implementation of caloric restriction for oncology research (CaReFOR): Is starving cancer cells in the clinical realm feasible?

Brittany A. Simone Pramila Rani Anne Kevin Ko Mak Sarich Kimberly Strickland Daniel Monti Adam C. Berger Nicole L. Simone

Research Article-Hematology & Medical Oncology (HMO)

October 09, 2017


Angiosarcoma: A rare cause of splenomegaly

Thiagarajah Balamurugan Shaun R. Preston Izhar N. Bagwan

Case Report-Hematology & Medical Oncology (HMO)

October 23, 2017


White rodlike crystals in multiple myeloma cells

Juan Zhang Mingyong Li Yuan He

Case Report-Hematology & Medical Oncology (HMO)

October 26, 2017


How does obesity influences anatomopathologic features in radical prostatectomy specimen? Importance of body fat mass distribution

Morán E Budía A Martínez-Sarmiento M Broseta E Cámara R Boronat F

Research Article-Hematology & Medical Oncology (HMO)

October 26, 2017


Bevacizumab in high grade glioma: Is there a subgroup that benefits?

George Rigakos Anastasios Kyriazoglou Anastasia Vernadou Sotiris Papadopoulos Evangelia Skarpidi Panagiotis Nomikos Constantinos Dardoufas George Nassioulas George Kouvatseas Olympia Spyri Stefanos Labropoulos Evangelia Razis

Research Article-Hematology & Medical Oncology (HMO)

June 15, 2017


Myeloproliferative neoplasms, thrombosis and paroxysmal nocturnal hemoglobinuria: Is this triad more frequent than we thought?

Gaidano V Geuna M Cignetti A Carnuccio F Bernabei P Santoro N Saglio G P Sivera

Case Report-Hematology & Medical Oncology (HMO)

June 19, 2017


Application of embryonic models for elaboration of anti-carcinogenic preparations of desired action

Aminov AV Mekhtiev AA

Research Article-Hematology & Medical Oncology (HMO)

June 19, 2017


Un exceptional cause of lymphocytic colitis: Brucellosis

Raida Ben Salah Faten Frikha Rim Kallel Boudawara T Bahloul Z

Case Report-Hematology & Medical Oncology (HMO)

June 19, 2017


Biology of DNMT3 and LSD1 inhibition in acute myeloid leukemia (AML)

Samantha Messina

Mini Review-Hematology & Medical Oncology (HMO)

June 23, 2017


Traditional Chinese medicine Tongxinluo stimulates coronary collateral growth in a pig myocardial infarction model

Gao-Feng Wang Sen Ye Jian-Guo Cui Naiquan Yang Ke Xu Shu-Hua Zhang Chun-Jian Li

Research Article-Hematology & Medical Oncology (HMO)

June 26, 2017


Long-term follow-up of curcumin treated MGUS/SMM patients – an updated single centre experience

Terry Golombick Terrence H. Diamond Arumugam Manoharan Rajeev Ramakrishna

Letter to Editor-Hematology & Medical Oncology (HMO)

April 29, 2017


Ganoderma lucidum on the inhibition of colorectal cancer

Hong Ye Alfred Bennett Jenson

Review Article-Hematology & Medical Oncology (HMO)

May 09, 2017


Follow-up examinations performed by radiation oncologists after radiotherapy in Japan

Osamu Tanaka Eiichi Yama Hironori Ichihashi Yuzo Yamada Junichi Ando Takayoshi Iida

Research Article-Hematology & Medical Oncology (HMO)

May 22, 2017


A rare case of autoimmune pancytopenia (AIP) preceded by refractory anemia: Possible involvement of cytomegalovirus (CMV) infection in pathogenesis

Nobuo Takemori Goro Imai Hirobumi Matsumura Toshio Fukuda Masaru Kojima

Case Report-Hematology & Medical Oncology (HMO)

May 29, 2017


Immunomodulatory drugs and their therapeutic effect in hematological malignancies through cereblon

Ota Fuchs

Review Article-Hematology & Medical Oncology (HMO)

May 31, 2017


What-about-the-neutrophils-phenotypes

Fernando Marcos Rodriguez Ivon Teresa Clara Novak

Review Article-Hematology & Medical Oncology (HMO)

May 31, 2017


Novel treatment of pulmonary embolism in a patient with sickle cell disease

Marium Husain Payal Desai Peter Bittenbender Eric Kraut Raymond Magorien

Case Report-Hematology & Medical Oncology (HMO)

March 03, 2017


Metastatic small cell carcinoma of the prostate in an octogenarian with significant response to first-line chemotherapy

Anthony Wood Nabil Adra Liang Cheng Roberto Pili

Case Report-Hematology & Medical Oncology (HMO)

March 07, 2017


Update on NSCLC tissue acquisition, processing, and profiling in the molecular age

Anna J. Conterato Adam R. Belanger Lonny B. Yarmus Jason A. Akulian

Review Article-Hematology & Medical Oncology (HMO)

March 11, 2017


A pilot study of chemotherapy and traditional plant medicine in hematology malignancy: Report of thirty-four cases

George Zhu Saboor-Yaraghi AA Dharmadhikari D Baer J

Research Article-Hematology & Medical Oncology (HMO)

March 22, 2017


Circumcision of children with hemophilia in local places

Goksel Leblebisatan

Commentary-Hematology & Medical Oncology (HMO)

March 22, 2017


Multiple electrode aggregometry in thrombocytopenic haemato-oncologic patients – Influence of haematologic variables

Elin Netland Opheim Torunn Oveland Apelseth Simon J. Stanworth Geir Egil Eide Tor Hervig

Research Article-Hematology & Medical Oncology (HMO)

March 27, 2017


Clinical response in osteogenic sarcoma patients treated with ultra-dilute medicines

Prasanta Banerji Pratip Banerji

Case Report-Hematology & Medical Oncology (HMO)

January 14, 2017


Clinical Utility of Circulating Tumor Cells – A Clinician’s Current View

Tar Choon AW

Research Article-Hematology & Medical Oncology (HMO)

January 23, 2017


Successful treatment with lenalidomide dexamethasone for second relapse of a patient with non-secretory multiple myeloma with extramedullary liver plasmacytomas: A case report

Gavriatopoulou Maria Terpos Evangelos Roussou Maria Migkou Magdalini Ntanasis-Stathopoulos Ioannis Kastritis Efstathios Meletios Athanasios Dimopoulos

Case Report-Hematology & Medical Oncology (HMO)

February 06, 2017


Utilization of splanchnic nerve radiofrequency lesioning for pain control in cholangiocarcinom

Brian Kahan

Short Communication-Hematology & Medical Oncology (HMO)

February 11, 2017


An overview on the role of autophagy in cancer therapy

Daniela Grácio Fernando Magro Raquel T. Lima Valdemar Máximo

Review Article-Hematology & Medical Oncology (HMO)

February 18, 2017


Volume 1

Brush border enzymuria originating from proximal renal tubules as sifted test in patients with psoriatic arthritis

Dejan Spasovski

Research Article-Hematology & Medical Oncology (HMO)

November 14, 2016


Preimplantation HLA typing for stem cell transplantation treatment of congenital and acquired bone marrow failures

Anver Kuliev Svetlana Rechitsky

Research Article-Hematology & Medical Oncology (HMO)

November 17, 2016


Ratios of selected chemical element contents in prostatic tissue as markers of malignancy

Vladimir Zaichick Sofia Zaichick

Research Article-Hematology & Medical Oncology (HMO)

November 26, 2016


The effect of the eccentric loading on the components of the spine

Samir Zahaf Bensamine Mansouri Abderrahmane Belarbi Zitouni Azari

Research Article-Hematology & Medical Oncology (HMO)

November 28, 2016


The characteristics of breast cancer in geriatric patients

Aybala Ağaç Ay Haluk Ulucanlar Selçuk Misirligil Ahmet Alyanak Saadet Akturan

Research Article-Hematology & Medical Oncology (HMO)

November 28, 2016


Hypersensitivity reactions to enoxaparin and unfractionated heparin in a pregnant woman with gestational thrombocytopenia: A case report

Fahad A S Al-Eidan Nourah Al-Qhtani Areej F Alsubaie Badria M Al-Nouh

Case Report-Hematology & Medical Oncology (HMO)

December 29, 2016


First report of homozygous factor VII Padua (Arg304Gln) defect in a family from Argentina

Girolami Antonio Arias Mirta Sueldo Emanuel Scoles Graciela Ferrari Silvia Lombardi Anna Maria

Research Article-Hematology & Medical Oncology (HMO)

July 04, 2016


The European clinical, molecular and pathological (Euro cmp → CMP) and WHO-CMP criteria of the myeloproliferative disorders 1940-2008 and myeloproliferative neoplasms 2008-2015

Jan Jacques Michiels Hendrik De Raeve

Review Article-Hematology & Medical Oncology (HMO)

July 16, 2016


Benign fibrous histiocytoma, case report

Monica D’Amato Gutiérrez Natalia Andrea Valencia Zuluaga Andrea Parra Buitrago David Andrés Espinal Botero

Case Report-Hematology & Medical Oncology (HMO)

August 22, 2016


Personalised/precision medicine

Shaun R. McCann

Short Communication-Hematology & Medical Oncology (HMO)

August 27, 2016


Downregulating oncogenic receptor: From bench to clinic

George Zhu Ali-Akmbar Saboor-Yaraghi Yosef Yarden Joana Santos Neil JC

Review Article-Hematology & Medical Oncology (HMO)

October 16, 2016


Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal Cells

Leland Metheny III Saada Eid Karen Lingas Jane Reese Howard Meyerson Alexander Tong Marcos de Lima Alex Y. Huang

Research Article-Hematology & Medical Oncology (HMO)

October 20, 2016


External Databases & Indexes


  • WorldCat
  • Crossref
  • Google scholar
  • Pubmed*
  • NSD*

Submit Manuscript


Hematology and Medical Oncology welcomes direct submissions from authors: Attach your word file with e- mail and send it to submissions@oatext.com alternatively to editor.hmo@oatext.com

Publication Charges


Hematology & Medical Oncology is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Hematology & Medical Oncology are GBP 1660.

Frequently Asked Questions (FAQs)

Why are your charges set at these levels?

All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

  • Recover capitalization costs;
  • Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
  • Bend the publication-charge cost downward over time.

Who will pay the APC?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

  1. Wire/Bank transfer
  2. Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after  processing of the manuscript.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Withdrawal Charges

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.

Special Issues


Stem Cells in Hematology


  • Editor Affiliation:

    Dr. Felicetto Ferrara
    Division of Hematology and Stem Cell Transplantation Unit
    Cardarelli Hospital
    Italy

Submission date: October 30, 2018
Publication date: November 15, 2018

Description of the Special Issue: Hematopoietic stem cells (HSCs) focus on molecular genetic mechanisms that regulate differentiation, self-renewal, and aging. Hematopoietic precursors are a useful model for adult stem cells in general for 2 reasons. First, they are essential, producing not only all erythroid, myeloid and lymphoid cells, but natural killer cells and mast cells; and, they produce the macrophages found in liver, lung, bone, brain, and other tissues. Second, they are a well-defined example of self-renewing and differentiating cells that illustrate methods applicable to other stem cell systems. Because differentiated cells turn over continually, constant stem cell proliferation is necessary. In fact, partial proliferative exhaustion can explain losses with age in the many tissues in which repair and function depend on regeneration from adult precursor cells. In general, any impairment of stem cell function with age would reduce health in many biological systems. Conversely, any improvement of stem cell function with age could prolong health in many biological systems.

Submit manuscript to: editor.hmo@oatext.com, editor@hematologyresearch.info


  • Thrombosis and Hemostasis in Surgery


Editor Affiliation:

Dr. Ciro Rinaldi
Lincoln University
England

Submission date: October 30, 2018
Publication date: November 15, 2018

Description of the Special Issue: This special issue on Thrombosis & Hemostasis focuses on challenges related to hemostatic and thromboembolic complications in surgery or trauma. Multiple factors contribute to perioperative bleeding or thromboembolic risk. These factors might be related to the individual patient (e.g., bleeding disorders, cancer, or developmental hemostatic changes in pediatric patients), to anticoagulant medication or complications such as heparin-induced thrombocytopenia (HIT), or to inherent risks of a particular surgical procedure or affected organ (e.g., hepatobiliary surgery or renal transplantation). All of these factors can have a profound effect on expected outcomes.

Submit manuscript to: editor.hmo@oatext.com, editor@hematologyresearch.info